Ibogaine In Texas? Where Texans Can Find Ibogaine Treatment

Texas is investing heavily in ibogaine research while keeping the medicine illegal for general use. This page walks through the current reality in 2026—what “ibogaine in Texas” actually means, how state‑funded trials change the picture, and where Texans legally seek treatment abroad.

Public information brief — not legal or medical advice.

Bottom line: Ibogaine is a psychoactive alkaloid with emerging therapeutic interest, but in the United States—including Texas—it remains a Schedule I substance. There is no legal prescribing or clinic use inside Texas outside narrowly defined, FDA‑approved research settings. At the same time, Texas has become the leading state funder of ibogaine research and is launching state‑backed clinical trials at institutions such as UTHealth Houston and UTMB.

$50M Texas SB 2308 allocates the largest single state investment in psychedelic research in the U.S.
80k–100k+ Annual U.S. overdose deaths in recent years; fentanyl a primary driver.
0 clinics General ibogaine treatment is illegal in Texas; research participation only.

The crisis Texas is aiming at

The U.S. remains above 80,000–100,000 annual overdose deaths, driven largely by synthetic opioids. Texas leaders have framed ibogaine research as a potential tool against opioid use disorder while making clear that the drug stays illegal for general use. Possession of ibogaine in Texas is a felony under state and federal Schedule I rules; penalties vary by weight and intent, and convictions carry serious consequences. Recent legislative moves in Texas also show a complex stance on drugs—tightening THC rules in some areas while funding psychedelics research.

Track opportunities without breaking the law. Get a single email when state research enrollment opens.
Get notified

What ibogaine is—and isn’t—in Texas

Ibogaine is a psychoactive alkaloid extracted from the root bark of Tabernanthe iboga, used traditionally in Bwiti ceremonies in Central and West Africa. Pharmacologically, it acts across several systems—including serotonin transporters and receptors, NMDA receptors, and kappa‑opioid receptors—producing an intense 12–24 hour psychedelic/dissociative experience. Clinical interest focuses on rapid reduction of opioid withdrawal symptoms and cravings, as well as potential impacts on PTSD, depression, and traumatic brain injury.

In Texas, the scope is narrow: no legal prescribing or clinic use; research participation only. Texans seeking treatment commonly travel to jurisdictions where ibogaine is legal or unscheduled (for example, clinics across the border in Mexico). For a neutral overview of the experience itself, see a detailed look at the ibogaine experience, hosted by a community resource describing typical phases, timelines, and safety considerations.

A lawful path for Texans: step by step

  1. Learn the legal boundaries. Ibogaine remains illegal to possess or use in Texas outside of specific research. Traveling with ibogaine across the U.S. border is illegal.
  2. Track Texas research openings. State‑funded institutions (e.g., UTHealth Houston and UTMB) are launching ibogaine trials. Participation involves screening and formal informed consent; trials do not constitute general medical access.
  3. Consider treatment tourism realities. Many Texans opt for clinics in nearby countries where ibogaine is permitted, with Mexico a common destination. A neutral overview of retreat formats can be found on a community page that surveys ibogaine retreats and clinics.
  4. Prioritize safety and screening. Ibogaine carries cardiac and other medical risks; responsible programs emphasize medical evaluations and monitoring. Notably, a 2024 study associated with Stanford reported that a protocol including magnesium for cardiac protection improved PTSD, anxiety, and depression in veterans with TBI.
  5. Document your process. Keep records of consultations, screening results, and travel—especially if you plan to discuss trial eligibility later.
Get a simple, printable checklist for lawful next steps and safety considerations.
Email me the checklist

Signals of momentum: policy and data points

Texas authorized and funded ibogaine research with SB 2308, allocating $50 million—reportedly the largest state investment in psychedelic research in the U.S. A 2024 study associated with Stanford found ibogaine, used with magnesium for cardiac protection, safely reduced PTSD, anxiety, and depression and improved functioning in veterans with TBI. Meanwhile, Texas criminal law on ibogaine remains unchanged. — Summarized from public reporting (e.g., Texas Tribune, June 2025).

2024
Veteran‑focused study linked to Stanford reports improved mental health outcomes with an ibogaine protocol incorporating magnesium.
June 2025
Gov. Abbott signs SB 2308; Texas designates $50M for ibogaine research and development. Criminal statutes do not change.
2026
Texas institutions (e.g., UTHealth Houston, UTMB) move to launch state‑backed ibogaine trials; public interest grows, including among veterans.

Texas Ibogaine Clinical Trials

Texas is launching state‑funded ibogaine trials led by public institutions such as UTHealth Houston and UTMB. These are research programs with strict eligibility criteria, medical screening, and informed consent—not general access to treatment. Participation occurs under approved protocols and does not change the legality of ibogaine outside research settings.

How to follow and prepare

  • Watch for enrollment notices. Trials announce inclusion/exclusion criteria and site locations. Enrollment may prioritize specific groups, including veterans.
  • Gather your records. Medical histories, medications, cardiac assessments, and substance‑use history are commonly reviewed in psychedelic trials.
  • Understand risks and monitoring. Ibogaine is associated with cardiac risk; responsible trials use careful screening and supervision, sometimes including supportive measures described in prior research.

If you’re interested, plan ahead—screening windows can be brief, and seats limited.

Ibogaine Treatment Centers Near Texas

There are no legal ibogaine clinics operating in Texas for general treatment. Many Texans instead travel to nearby countries—most commonly Mexico—where private clinics and retreats operate under local law. This “treatment tourism” has grown precisely because ibogaine remains Schedule I in the U.S.

Due diligence for out‑of‑country care

  • Understand the law at your destination and at home; never transport ibogaine across borders.
  • Evaluate programs for medical screening, cardiac monitoring, and aftercare planning.
  • Seek neutral information first; a community overview of retreat formats and considerations is available on ibogaine.wiki’s retreats survey.

Even when traveling legally abroad, Texans remain subject to U.S. law upon return; do not import controlled substances. Private programs are not substitutes for emergency care or for the protections and oversight present in clinical trials.

Take the next lawful step

Texas is funding research, not legalizing treatment. If you’re exploring options, decide whether you’re aiming for a clinical trial in‑state or a legally operated program abroad—and prepare accordingly.

One message when trials open, plus a printable safety and law checklist.
Send me the update

Quick FAQ

Is ibogaine legal to use in Texas?

No. Ibogaine is a Schedule I substance federally and in Texas. Possession and use are illegal outside of narrowly defined, FDA‑approved research.

What changed with SB 2308?

Texas allocated $50 million for ibogaine research and development. The law funds studies but does not legalize ibogaine for general treatment.

Where are Texans getting ibogaine treatment now?

Many travel to countries where ibogaine is legal or unscheduled—often Mexico—while others await enrollment opportunities in Texas‑based clinical trials.